Abstract
Objective: To measure fertility-related quality of life using the Fertility Quality of Life (FertiQol) instrument and to identify the sociodemographic characteristics of women diagnosed with gynecological cancer who are monitored at a cancer center in Amazonas. Methods: This is a cross-sectional observational study, since it does not seek to impose any treatment. We only sought to apply the sociodemographic questionnaire and the FertiQol instrument to female patients between 18 and 40 years of age, diagnosed with gynecological cancer, at any stage. Results: The research aimed to contribute with qualified information on oncofertility in the State of Amazonas. Among the main results, the following stand out: the identification of the sociodemographic characteristics of the participants, as well as the correlation between the quality of life obtained with the FertiQol of patients diagnosed with gynecological cancer who are followed up at an oncological center in Amazonas. Conclusion: According to the data obtained, 93% of the population studied has at least one child, this is a population of low socioeconomic status and has a low emotional, social and family impact in the face of a probable diagnosis of infertility resulting from cancer treatment, as a result, this group is not concerned with fertility preservation.
References
BEN-AHARON I, et al. Optimizing the process of fertility preservation in pediatric female cancer patients – a multidisciplinary program. BMC Cancer, 2016; 16: 620.
BOIVIN J, et al. The fertility quality of life (FertiQoL) tool: development and general psychometric properties. Human Reproduction, 2011; 26(8): 2084–2091,
FREDDIE B, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: A Cancer Journal for Clinicians, 2018; 68: 394-424.
GARDINO SL, et al. Using decision trees to enhance interdisciplinary team work: the case of oncofertility. J Assist Reprod Genet, 2010; 27: 227–231
GORMAN J, et al. A multidimensional scale to measure the reproductive concerns of young adult female cancer survivors. J Cancer Surviv, 2013.
JERUSS JS, et al. Preservation of Fertility in Patients with Cancer. N Engl J Med., 2009; 360: 902-911
LAMBERTINI M, et al. Cancer and fertility preservation: international recommendations from an expert meeting. BMC Medicine, 2016; 14: 1.
LEE SJ, et al. American Society of Clinical Oncology Recommendations on Fertility Preservation in Cancer Patients. Journal of Clinical Oncology, 2006; 24(18): 2917-31.
LETOURNEAU JM, et al. Pretreatment fertility counseling and fertility preservation improve quality of life in reproductive age women with cancer. Cancer, 2012; 118(6): 1710-17.
LOREN, A.W, et al. Fertility preservation for patients with cancer: American Society of Clinical Oncology clinical practice guideline update. Journal of Clinical Oncology, 2013; 31: 2500-2510
MAHAJAN N. Fertility preservation in female cancer patients: An overview. Journal of Human Reproductive Sciences, 2015; 8: 3-12.
PARTRIDGE AH, et al. Web-based survey of fertility issues in young women with breast cancer. Journal of Clinical Oncology, 2004; 22(20): 4174-83.
PEATE, M, et al. The fertility-related concerns, needs and preferences of younger women with breast cancer: a systematic review. Breast Cancer Res Treat., 2009; 116(2): 215-23.
PEDRESCHI LE. O tratamento centrado no paciente e a RHA: validação da versão brasileira do PCQ – Infertilidade [mestrado]. Coimbra: Universidade de Coimbra, Faculdade de Economia da Universidade de Coimbra; 2016.
QUINN GP, et al. Discussion of fertility preservation with newly diagnosed patients: oncologists’ views. Journal of Cancer Survivorship, 2007; 1: 46–155.
SHNORHAVORIAN M, et al. Fertility preservation knowledge, counseling, and actions among adolescent and young adult patients with cancer: a population-based study. Cancer, 2015; 3499-3506.
SIEGEL RL, et al. Cancer statistics, 2022.CA Cancer J Clin., 2022; 72: 7–33.
SUNG H, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: A Cancer Journal for Clinicians, 2021; 71: 209-249.
SUZUKI N. Oncofertility in Japan: advances in research and the roles of oncofertility consortia, 2016; 12.
WOODRUFF TK. The Oncofertility Consortium - addressing fertility in young people with cancer. Nat Rev Clin.Oncol, 2010; 7: 466-475.
YEE S. Factors associated with the receipt of fertility preservation services along the decision-making pathway in young Canadian female cancer patients. J Assist Reprod Genet., 2016.
